Krebs Biochemicals & Industries Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

21.56

21.56

19.62

18.00

16.63

Share application money

-

-

4.17

7.65

-

Preference share capital

130.00

130.00

-

-

-

Reserves & surplus

-121.02

-96.65

-66.52

-50.65

-30.92

Loan funds

Secured loans

53.24

12.92

100.55

65.51

-

Unsecured loans

-

-

-

-

50.23

Total

83.77

67.82

57.81

40.51

35.94

Uses of funds

Fixed assets

Gross block

301.06

286.16

259.72

242.22

233.78

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

153.75

147.45

141.79

136.93

132.51

Net block

147.31

138.71

117.93

105.29

101.27

Capital work-in-progress

4.09

8.38

11.94

4.19

3.48

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

23.58

42.72

29.36

24.32

37.62

Less : current liabilities & provisions

91.21

121.98

101.41

93.29

106.43

Total net current assets

-67.62

-79.26

-72.05

-68.97

-68.81

Miscellaneous expenses not written

-

-

-

-

-

Total

83.77

67.82

57.81

40.51

35.94

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

5.63

5.55

5.53

4.84

5.95

Number of equity sharesoutstanding (Lacs)

215.60

215.60

196.20

180.00

166.30